Sawai Pharmaceutical Co Has Reached Settlement With Asahi Kasei Pharma Regarding Patent Infringement Lawsuit Concerning Teriparatide For Subcutaneous Injection 56.5μg
Oct 21 (Reuters) - Asahi Kasei Corp 3407.T: SAWAI GROUP HOLDINGS CO - SAWAI PHARMACEUTICAL CO HAS REACHED SETTLEMENT WITH ASAHI KASEI PHARMA REGARDING PATENT INFRINGEMENT LAWSUIT CONCERNING TERIPARATIDE FOR SUBCUTANEOUS INJECTION 56.5ΜG SAWAI GROUP HOLDINGS CO - SAWAI PHARMACEUTICAL PAID ASAHI KASEI PHARMA 4 BILLION YEN AS A SETTLEMENT, AND ASAHI KASEI PHARMA WAIVED ANY OTHER CLAIMS AGAINST SAWAI PHARMACEUTICAL Source text: ID:nTSvt8c9e2 Further company coverage: 3407.T
Recent news on ASAHI KASEI
See all newsBrief: Asahi Kasei Corporation - Subsidiary To Launch Tender Offer For Shares Of Mori-Gumi
Table: ASAHI KASEI -6-MTH group results
Brief: Asahi Kasei Corporation - Announces Cancellation Of Treasury Shares
US FDA approves Asahi Kasei's drug for persistent herpes infections
Table: Asahi Kasei -Q1 group results